Early Stage Parkinson Disease (DBCOND0035449)

Identifiers

Synonyms

Early Parkinson's Disease (PD) / Early-stage parkinson / Early-Stage Parkinson's Disease / Early Stage Parkinson's Disease / Early Parkinson's Disease / Early Parkinson Disease / Early Parkinson Disease (Early PD)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04658186	A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease	Minzasolmin	treatment	2	completed
NCT01048229	Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease	Pramipexole Rasagiline	treatment	4	terminated
NCT00594165	An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.	Rotigotine	treatment	3	completed
NCT04033393	Dual-task Performance in Young-onset PD	No drug interventions	treatment	Not Available	unknown_status
NCT00335166	SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease	Pramipexole	treatment	3	completed
NCT00623324	The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease	Aplindore	treatment	2	completed
NCT00599196	An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease	Rotigotine	treatment	3	completed
NCT00332917	An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients	Pardoprunox	treatment	3	completed
NCT00269516	SLV308 for Treatment of Patients With Early Parkinson's Disease	Pardoprunox	treatment	3	completed
NCT00335374	An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients	Pardoprunox	treatment	3	completed
NCT03329508	A Phase 3 Study With P2B001 in Subjects With Early Parkinson's	Pramipexole Rasagiline	treatment	3	completed
NCT00537485	A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients	Rotigotine	treatment	2 / 3	completed
NCT04269642	SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease	No drug interventions	treatment	2	unknown_status
NCT00809302	Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease	No drug interventions	treatment	2	terminated
NCT03655236	PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706	Vodobatinib	treatment	2	terminated
NCT00479401	Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients	Pramipexole	treatment	3	completed